Abstract
Injection ofl-p-tyrosine (800 mg/kg, 2 h) increased the mouse striatalpara-hydroxyphenylacetic acid (p-HPAA) concentrations. A smaller dose ofd,l-m-tyrosine (20 mg/kg, 2h) produced a larger increase in mouse striatalmeta-hydroxyphenylacetic acid (m-HPAA) concentrations. The administration ofl-phenylalanine to mice caused a slight increase in thep-HPAA concentrations in the corpus striatum after 2h while a larger dose ofl-phenylalanine (800 mg/kg) produced a greater increase. Eight hours followingl-phenylalanine injection,p-HPAA concentrations were still elevated. Withd-phenylalanine a significant increase was observed at eight hours after drug administration.
Two drugs which reduce dopamine synthesis, α-methyl-para-tyrosine and apomorphine, decreasedm-HPAA striatal concentrations without affectingp-HPAA concentrations. From these results, it is proposed that tyrosine hydroxylase activity determinesp-HPAA concentrations by regulatingp-tyrosine availability. This enzyme may also synthesizem-tyrosine which is subsequently decarboxylated to formm-tyramine and then oxidatively deaminated to formm-HPAA.
Similar content being viewed by others
References
Blum, L. 1908. Uber den abbau aromatischer substantzen im menschlichen organismus. Arch. Exp. Path. Pharmak. 59:273–298.
Flatow, L. 1910. Uber den abbau von aminosauren im organismus. Hoppe-Seyl. Z. 64:367–392.
Pogrund, R. S., Drell, W., andClark, W. G. 1961. Metabolism of 3-hydroxy and 3,4-dihydroxyphenylpyruvic acids in vivo. J. Pharmacol. Exp. Ther. 131:294–307.
Juorio, A. V., andBoulton, A. A. 1982. The effect of some precursor amino acids and enzyme inhibitors on the mouse striatal concentrations of tyramines and homovanillic acid. J. Neurochem. 39:859–863.
Oster, K. A., andSchlossman, N. C. 1942. Histochemical demonstration of amine oxidase in the kidney. J. Cell. Comp. Physiol. 20:373–378.
McQuade, P. S., Juorio, A. V., andBoulton, A. A. 1981. Estimation of thep- andm-isomers of hydroxyphenylacetic acid in mouse brain by a gas chromatographic procedure: their distribution and the effects of some drugs. J. Neurochem. 37:735–739.
Karoum, F., Gillin, J. C., Wyatt, R. J., andCosta, E. 1975. Mass fragmentography of nanogram quantities of biogenic amine metabolites in human cerebrospinal fluid and whole rat brain. Biomed. Mass. Spectrom. 2:183–189.
Durden, D. A., and Boulton, A. A. 1981. Identification and distribution ofm- andp-hydroxyphenylacetic acids in the brain of the rat. J. Neurochem. 36:129–135.
Chirigos, M. A., Greengard, P., andUdenfriend, S. 1960. Uptake of tyrosine by rat brain in vivo. J. Biol. Chem. 235:2075–2079.
Gibson, C. J., andWurtman, R. J. 1978. Physiological control of brain norepinephrine synthesis by brain tyrosine concentration. Life Sci. 22:1399–1406.
Carlsson, A., andLindquist, M. 1978. Dependence of 5-HT and catecholamine synthesis on concentrations of precursor amino acids in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 303:157–164.
Sved, A., andFernstrom, J. 1981. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma butyrolactone. Life Sci. 29:743–748.
Boulton, A. A., andHuebert, N. D. 1981. Biosynthesis of some urinary trace amines in the rat and the human. Res. Commun. Chem. Pathol. Pharmacol. 34:295–310.
Faull, K. F., Gan, I., Halpern, B., Hammond, J., Im, S., Cotton, R. G. H., Danks, D. M., andFreeman, R. 1977. Metabolic studies on two patients with nonhepatic tyrosinemia using deuterated tyrosine loads. Pediat. Res. 11:631–637.
Edwards, D. J., andRizk, M. 1981. Effects of amino acid precursors on catecholamine synthesis in the brain. Prog. Neuropsychopharmacol. 5:569–572.
Edwards, D. J. 1982. Possible role of octopamine and tyramine in the antihypertensive and antidepressant effects of tyrosine. Life Sci. 30:1427–1434.
Miller, J. E., andLitwack, G. 1969. Subcellular distribution of tyrosine aminotransferase in rat brain. Arch. Biochem. Biophys.134:149–159.
Ohisalo, J. J., Andersson, B. M., Viljanen, A. A., andAnderson, S. M. 1982. Is there a brain tyrosine aminotransferase? Biochem. J. 204:621–622.
Mitoma, C., Posner, H. S., Bogdanski, D. F., andUdenfriend, S. 1957. Biochemical and pharmacological studies ono-tyrosine and itsmeta andpara analogues. A suggestion concerning phenylketonuria. J. Pharmacol. Exp. Ther. 120:188–194.
Fell, U., Greenway, A. M., andHoskins, J. A. 1979. The metabolism ofl-m-tyrosine in man. Biochem. Med. 22:246–255.
Saavedra, J. M. 1974. Enzymatic isotopic assay for and presence of β-phenylethylamine in brain. J. Neurochem. 22:211–216.
Boulton, A. A., Dyck, L. E., andDurden, D. A. 1974. Hydroxylation of β-phenylethylamine in the rat. Life Sci. 15:1673–1683.
McQuade, P. S., andJuorio, A. V. 1982. The effects of the administration of β-phenylethylamine on tyramine metabolism. Eur. J. Pharmacol. 83:277–282.
Ikeda, M., Levitt, M., andUdenfriend, S. 1965. Hydroxylation of phenylalanine by purified preparations of adrenal and brain tyrosine hydroxylase. Biochem. Biophys. Res. Commun. 18:482–488.
Hoskins, J. A. 1977. The formation ofmeta-hydroxyphenylacetic acid through a direct ring hydroxylation reaction in humans.Biochem. Biophys. Res. Commun. 77:50–56.
Spatz, H., andSpatz, N. 1978. Urinary and brain phenylethylamine levels under normal and pathological conditions. Pages 447–474,in A. Mosnaim, andM. Wolf (eds.) Noncatecholic Phenylethylamines: Biological Mechanisms and Clinical Aspects, Part 1, Marcel Dekker, New York.
Mosnaim, A. D., Inwang, E. E., andSabelli, H. C. 1974. The influence of psychotropic drugs on the levels of 2-phenylethylamine in rabbit brain. Biol. Psychiatry 8:227–234.
Spector, S., Sjoerdsma, A. andUdenfriend, S. 1965. Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 147:86–95.
Juorio, A. V. 1979. Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse. Br. J. Pharmacol. 66:377–384.
Duffield, P. H., Dougan, D. F. H., Wade, D. N. andDuffield, A. M. 1981. A chemical ionization gas chromatographic mass spectrometric assay for octopamine and tyramine in rat brain. Biomed. Mass Spectrom. 8:170–173.
Roos, B. E. 1969. Decrease in homovanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J. Pharm. Pharmacol. 21:263–264.
Bunney, B. S., Walters, J. R., Roth, R. H., andAghajanian, K. 1973. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185:560–571.
Kehr, W., Carlsson, A., andLindquist, M. 1975. Biochemical aspects of dopamine agonists. Pages 185–196,in D. Calne, J. N. Chase, andA. Barbeau (eds.) Dopaminergic Mechanisms, Advances in Neurology, Vol. 9, Raven Press, New York.
Goldstein, M., Freedman, L. S., andBackstrom, T. 1970. The inhibition of catecholamine biosynthesis by apomorphine. J. Pharm. Pharmacol. 22:715–717.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McQuade, P.S., Juorio, A.V. The effect of various amino acids and drugs on thepara-andmeta-hydroxyphenylacetic acid concentrations in the mouse caudate nucleus. Neurochem Res 8, 903–912 (1983). https://doi.org/10.1007/BF00964551
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00964551